Zhuoyu Gu
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 18, 2025
Targeting the Gut-Heart Axis: Dextran from Gut-Derived Weissella cibaria Alleviates Doxorubicin-Induced Cardiotoxicity by Attenuating Low-Grade Endotoxemia.
Journal: Journal of agricultural and food chemistry
Published: December 17, 2025
Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study.
Journal: BMC cancer
Published: November 15, 2025
Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R-Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 25, 2025
Key Toxic Genes and Mechanisms of Di(2-ethylhexyl) Phthalate-Induced Non-Alcoholic Fatty Liver Disease: A Multi-Omics Study.
Journal: Current medicinal chemistry
Published: September 17, 2025
SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker in lung adenocarcinoma.
Journal: Frontiers in immunology
Published: September 04, 2025
HNRNPD/MAD2L2 axis facilitates lung adenocarcinoma progression and is a potential prognostic biomarker.
Journal: Cellular signalling
Published: July 25, 2024
Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
Journal: Journal of cellular and molecular medicine
Published: November 03, 2023
SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.
Journal: International journal of oncology
Published: October 20, 2023
Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients.
Journal: Cellular signalling
Published: October 12, 2023
Targeting TIGIT for cancer immunotherapy: recent advances and future directions.
Journal: Biomarker research
Published: September 28, 2023
Last Updated: 09/26/2026